Evidence map›Paper›PMID 25416780›Full record

ArticleThe Journal of biological chemistry2015

Late onset neuropathy with spontaneous clinical remission in mice lacking the POZ domain of the transcription factor Myc-interacting zinc finger protein 1 (Miz1) in Schwann cells.

Adrián Sanz-Moreno, David Fuhrmann, Armin Zankel, Herbert Reingruber, Lara Kern, Dies Meijer, Axel Niemann, Hans-Peter Elsässer

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Miz1 Controls Schwann Cell Proliferation via H3K36The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Adrián Sanz-MorenoFrom the Department of Cytobiology and Cytopathobiology, Philipps University of Marburg, Robert-Koch-Strasse 6, 35033 Marburg, Germany.
David FuhrmannFrom the Department of Cytobiology and Cytopathobiology, Philipps University of Marburg, Robert-Koch-Strasse 6, 35033 Marburg, Germany.
Armin ZankelGraz University of Technology, 8010 Graz, Austria.
Herbert ReingruberGraz University of Technology, 8010 Graz, Austria.
Lara KernFrom the Department of Cytobiology and Cytopathobiology, Philipps University of Marburg, Robert-Koch-Strasse 6, 35033 Marburg, Germany.
Dies MeijerErasmus Medical Center, 3015GE Rotterdam, Netherlands, and.
Axel NiemannETH Zurich, CH-8093 Zurich, Switzerland.
Hans-Peter ElsässerFrom the Department of Cytobiology and Cytopathobiology, Philipps University of Marburg, Robert-Koch-Strasse 6, 35033 Marburg, Germany, elsaesse@mailer.uni-marburg.de.
Graz University of Technology · ATETH Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transcription factor Miz1 (Myc-interacting zinc finger 1) is a known regulator of the cell cycle but also has cell cycle-independent functions. Here we analyzed the role of Miz1 in the peripheral nervous system, using an early embryonic conditional knock-out model in which the Miz1 POZ domain is ablated in Schwann cells. Although the development of myelinated nerve fibers was not impaired, Miz1ΔPOZ mice acquired behavioral signs of a peripheral neuropathy at the age of 3 months. At this time, ultrastructural analysis of the sciatic nerve showed de- and dysmyelination of fibers, with massive outfoldings and a focal infiltration of macrophages. Although the expression of genes encoding structural myelin proteins, such as periaxin, myelin basic protein, and myelin protein zero, was decreased, genes associated with a negative regulation of myelination, including c-Jun, Sox2, and Id2, were up-regulated in Miz1ΔPOZ mice compared with controls. In animals older than 4 months, the motor disabilities vanished, and the ultrastructure of the sciatic nerve exhibited numerous tomacula and remyelinated fibers, as indicated by thinner myelin. No second acute attack was observed up to the age of 1 year. Thus, the deletion of the Miz1 POZ domain in Schwann cells induces an acute neuropathy with a subsequent regeneration in which there is ongoing balancing between de- and remyelination. Miz1ΔPOZ mice are impaired in the maintenance of myelinated fibers and are a promising model for studying remyelination in adult peripheral nerves.

Indexed as

AnimalsGene Expression Regulation, DevelopmentalHumansMiceMice, KnockoutMyelin SheathNerve Fibers, MyelinatedNerve RegenerationNuclear ProteinsPeripheral Nervous SystemPeripheral Nervous System DiseasesProtein Inhibitors of Activated STATProtein Structure, TertiarySchwann CellsSciatic NerveUbiquitin-Protein LigasesMiz1 protein, mouseNuclear ProteinsProtein Inhibitors of Activated STATUbiquitin-Protein LigasesHomeostasisMiz1MyelinNeurodegenerative DiseaseRegenerationRemitting NeuropathySchwann CellsTranscription Factor

Identifiers

PMID25416780
PMCPMC4294497
OpenAlexW2034643397

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.